[ORGANIZATION]
National Institute for Bioprocess Research and Training
Featured in 1 tracked story · first seen
Situations
GLP‑1 market, usage, safety & new guidance
180 clusters · 643 sources · last updated
Latest: GLP‑1 weight‑loss drugs guided by new consensus on protein and resistance training
GLP‑1 receptor agonists continue to dominate weight‑loss therapy, now reaching primary‑care, tele‑health and Medicare coverage, with market value projected near $105 billion by 2030. Safety monitoring confirms a modest i